Zobrazeno 1 - 10
of 190
pro vyhledávání: '"Ioannis, Psallidas"'
Autor:
Annika Åstrand, Cecilia Wingren, Claire Walton, Johan Mattsson, Komal Agrawal, Madelene Lindqvist, Lina Odqvist, Björn Burmeister, Steven Eck, Glen Hughes, Gabriela Luporini Saraiva, Anna Schantz, Ioannis Psallidas, Christopher McCrae
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/f5cad6e900424cb396d36459f878b7bc
Autor:
Jianlong Jia, Antonia Marazioti, Apostolos Voulgaridis, Ioannis Psallidas, Anne-Sophie Lamort, Marianthi Iliopoulou, Anthi C. Krontira, Ioannis Lilis, Rachelle Asciak, Nikolaos I. Kanellakis, Najib M. Rahman, Kyriakos Karkoulias, Konstantinos Spiropoulos, Ruonan Liu, Jan-Christian Kaiser, Georgios T. Stathopoulos
Publikováno v:
Translational Oncology, Vol 39, Iss , Pp 101800- (2024)
Introduction: Pleural effusions frequently signal disseminated cancer. Diagnostic markers of pleural malignancy at presentation that would assess cancer risk and would streamline diagnostic decisions remain unidentified. Methods: A consecutive cohort
Externí odkaz:
https://doaj.org/article/e8ac2e971c864332b05a9e56510b480a
Autor:
Princess Ogbogu, Amy Klion, Florence Roufosse, Praveen Akuthota, Paneez Khoury, Vivian Shih, Dianne Griffis, Himanshu Parikh, Ron Chen, Ying Fan, Gaell Mayer, Priya Jain, Rohit Katial, Ioannis Psallidas
Publikováno v:
HemaSphere, Vol 7, p e5623859 (2023)
Externí odkaz:
https://doaj.org/article/55246ccfcafc46c8871ee1a92e9efe7f
Autor:
Nikolaos I Kanellakis, PhD, John M Wrightson, DPhil, Stephen Gerry, PhD, Nicholas Ilott, PhD, John P Corcoran, MRCP, Eihab O Bedawi, MRCP, Rachelle Asciak, MD, Andrey Nezhentsev, BA, Anand Sundaralingam, MRCP, Rob J Hallifax, DPhil, Greta M Economides, BA, Lucy R Bland, BA, Elizabeth Daly, BA, Xuan Yao, PhD, Nick A Maskell, ProfDM, Robert F Miller, ProfFRCP, Derrick W Crook, ProfFRCP, Timothy S C Hinks, PhD, Tao Dong, ProfDPhil, Ioannis Psallidas, PhD, Najib M Rahman, ProfDPhil
Publikováno v:
The Lancet Microbe, Vol 3, Iss 4, Pp e294-e302 (2022)
Summary: Background: Pleural infection is a common and severe disease with high morbidity and mortality worldwide. The knowledge of pleural infection bacteriology remains incomplete, as pathogen detection methods based on culture have insufficient se
Externí odkaz:
https://doaj.org/article/6ba777750bb44518b8317bbae6d231de
Autor:
Antonia Marazioti, Anthi C Krontira, Sabine J Behrend, Georgia A Giotopoulou, Giannoula Ntaliarda, Christophe Blanquart, Hasan Bayram, Marianthi Iliopoulou, Malamati Vreka, Lilith Trassl, Mario A A Pepe, Caroline M Hackl, Laura V Klotz, Stefanie A I Weiss, Ina Koch, Michael Lindner, Rudolph A Hatz, Juergen Behr, Darcy E Wagner, Helen Papadaki, Sophia G Antimisiaris, Didier Jean, Sophie Deshayes, Marc Grégoire, Özgecan Kayalar, Deniz Mortazavi, Şükrü Dilege, Serhan Tanju, Suat Erus, Ömer Yavuz, Pınar Bulutay, Pınar Fırat, Ioannis Psallidas, Magda Spella, Ioanna Giopanou, Ioannis Lilis, Anne‐Sophie Lamort, Georgios T Stathopoulos
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 2, Pp n/a-n/a (2022)
Abstract Malignant pleural mesothelioma (MPM) arises from mesothelial cells lining the pleural cavity of asbestos‐exposed individuals and rapidly leads to death. MPM harbors loss‐of‐function mutations in BAP1, NF2, CDKN2A, and TP53, but isolate
Externí odkaz:
https://doaj.org/article/575673597fcf4a4d8c11cf61042aed68
Autor:
Dave Singh, Victor Balaguer, Carol Astbury, Ulrika Wählby-Hamrén, Eulalia Jimenez, Beatriz Seoane, Cristina Villarroel, Alejhandra Lei, Ajay Aggarwal, Ioannis Psallidas
Publikováno v:
Respiratory Research, Vol 21, Iss S1, Pp 1-11 (2020)
Abstract Background Navafenterol (AZD8871) is a dual-pharmacology muscarinic antagonist β2−agonist (MABA) molecule in development for the treatment of chronic obstructive pulmonary disease (COPD). The pharmacodynamics, safety and tolerability of s
Externí odkaz:
https://doaj.org/article/93216040456b455fbf133449fada5043
Autor:
Eulalia Jimenez, Carol Astbury, Muna Albayaty, Ulrika Wählby-Hamrén, Beatriz Seoane, Cristina Villarroel, Helena Pujol, Maria Jesus Bermejo, Ajay Aggarwal, Ioannis Psallidas
Publikováno v:
Respiratory Research, Vol 21, Iss S1, Pp 1-9 (2020)
Abstract Background Navafenterol (AZD8871) is an inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist (MABA) in development for the treatment of obstructive airways diseases. The safety, tolerability, pharmacodynamics,
Externí odkaz:
https://doaj.org/article/5eb0ee5d18dd4886a2482e4d36b7db73
Autor:
Victor Balaguer, Muna Albayaty, Eulalia Jimenez, Ulrika Wählby-Hamrén, Carol Astbury, Beatriz Seoane, Marie-Pierre Malice, Alejhandra Lei, Ajay Aggarwal, Ioannis Psallidas
Publikováno v:
Respiratory Research, Vol 21, Iss S1, Pp 1-12 (2020)
Abstract Background Navafenterol (AZD8871) is a novel, long-acting, dual-pharmacology (muscarinic receptor antagonist and β2−adrenoceptor agonist) molecule in development for chronic obstructive pulmonary disease and asthma. Methods These two phas
Externí odkaz:
https://doaj.org/article/87c4d69744414d70839c9c48ca61b5f7
Autor:
Rachelle Asciak, Nikolaos I. Kanellakis, Xuan Yao, Megat Abd Hamid, Rachel M. Mercer, Maged Hassan, Eihab O. Bedawi, Melissa Dobson, Peter Fsadni, Stephen Montefort, Tao Dong, Najib M. Rahman, Ioannis Psallidas
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesPatients with malignant pleural mesothelioma (MPM) or pleural metastases often present with malignant pleural effusion (MPE). This study aimed to analyze the effect of pleural fluid on cancer cells.Materials and MethodsEstablished patient-d
Externí odkaz:
https://doaj.org/article/9ed8682f78464949aeaeef30ac7453b4
Autor:
Joshua D Freedman, Joachim Hagel, Eleanor M Scott, Ioannis Psallidas, Avinash Gupta, Laura Spiers, Paul Miller, Nikolaos Kanellakis, Rebecca Ashfield, Kerry D Fisher, Margaret R Duffy, Leonard W Seymour
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 8, Pp 1067-1087 (2017)
Abstract Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group B adenovirus EnAdenotucirev (EnAd) to express a bi
Externí odkaz:
https://doaj.org/article/65cb8311f33a4664948ad2d02957a40c